Targeted ultrasonographic screening for nuchal fluid accumulation duri
ng the first trimester (9-13 weeks) seems to be a recommendable method
for the detection of Down's syndrome and other chromosomal anomalies
in pregnant women. It compares favorably with current methods of mater
nal serum screening performed during the second trimester. Using a 4-m
m cut-off value, the detection rate of aneuploidy among our population
was found to be 57.1% with a false-positive rate of 0.7% and a positi
ve predictive value of 72.7%. Chromosomal analysis should be considere
d for fetuses with nuchal translucency equal to or greater than 4 mm i
n the first trimester.